ST. LOUIS, Dec. 13, 2011 /PRNewswire/ -- Stereotaxis, Inc. (NASDAQ: STXS) today announced that the Company has started initial shipments of the Epoch platform, its comprehensive solution for the electrophysiology (EP) lab that is designed to increase efficiency in procedures with a fully-remote, networked robotic and magnetic navigation system. Initial shipments include system upgrades to the new generation Epoch platform from the Niobe® II navigation system for customers in North America and Europe. As part of the Epoch upgrades, centers in Europe will also install the Company's Vdrive Duo™ mechanical arm robotic navigation system. The Vdrive Duo arm allows physicians to remotely manipulate a growing array of devices, such as the loop diagnostic catheter and sheath, while also manipulating the magnetic catheter.
Stereotaxis Announces Initial Shipments Of The Epoch™ Platform To Customers
Check Out Our Best Services for Investors
Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.